Skip to main content
LRMR
NASDAQ Life Sciences

Larimar Therapeutics Sets June 2026 BLA Target for Nomlabofusp, Q2 Topline Data Expected

Tom Rudovsky · Reported by Wiseek News
More coverage: Biotech Stocks · Healthcare
Sentiment info
Positive
Importance info
8
Price
$5.769
Mkt Cap
$487.009M
52W Low
$1.61
52W High
$6.42
52W Position info
258% above low
Off High info
10% below high
Rel. Volume info
0.9× avg
Market data snapshot near publication time

LRMR has more than doubled off its 52-week low of $1.61.

Summary

The news from Larimar Therapeutics provides crucial updates on its lead drug, nomlabofusp, including a target BLA submission in June 2026 for accelerated approval and anticipated Q2 2026 topline open-label data. This follows the recent FDA Breakthrough Therapy Designation announced in late February. The company also confirmed FDA alignment on key regulatory aspects, such as skin FXN as a potential surrogate endpoint. Additionally, the updated corporate presentation details a pro forma cash runway into Q2 2027, which is important context following the recent $100 million public offering. These specific timelines and regulatory clarity are significant catalysts for the stock, offering a clear roadmap for the drug's development and potential market entry.

At the time of this announcement, LRMR was trading at $5.77 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $487M. The 52-week trading range was $1.61 to $6.42. This news item was assessed with positive market sentiment and an importance score of 8 out of 10. Source: Wiseek News.


Price Chart

Share this article

Copied!

LRMR - Latest Insights

LRMR
Nov 16, 2026, 8:32 AM EST
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $3.00
Real-time Price: $2.88 info
Change: -$0.1225 (-4%) info
Market Cap: $328.553M info
LRMR
Nov 16, 2026, 7:17 AM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $2.90
Real-time Price: $2.88 info
Change: -$0.0225 (-0.78%) info
Market Cap: $328.553M info
LRMR
Nov 12, 2026, 6:02 PM EST
Filing Type: 4
Importance Score:
7
Price at Filing: $2.73
Real-time Price: $2.88 info
Change: +$0.1475 (+5%) info
Market Cap: $328.553M info
LRMR
Nov 09, 2026, 4:08 PM EST
Filing Type: 8-K
Importance Score:
8
Price at Filing: $2.53
Real-time Price: $2.88 info
Change: +$0.3475 (+14%) info
Market Cap: $328.553M info
LRMR
Aug 04, 2026, 7:12 AM EDT
Filing Type: 10-Q
Importance Score:
9
Price at Filing: $3.95
Real-time Price: $2.88 info
Change: -$1.07 (-27%) info
Market Cap: $328.553M info